Decreased PRS-I activity is predominantly characterized by sensorineural hearing loss with variable symptoms of optic atrophy, ataxia, peripheral neuropathy, delayed motor development, and intellectual disability. This evidence concerns the gene PRPS1 and peripheral neuropathy.